Novate Medical Ltd. is a privately held medical device company founded in 2006 and focused on the prevention of pulmonary embolism in patients at high risk of venous thromboembolic events. The companys lead product, called Sentry, is the first bio-convertible IVC filter. It is designed to provide protection against PE during the patients high risk period and then to bioconvert to leave an unobstructed IVC lumen after a minimum of sixty (60) days. This unique feature removes the requirement for an additional interventional procedure to retrieve the device. Novate is headquartered in Ireland and has offices in Ireland, the United Kingdom and the United States. It operates under the quality system requirements of ISO 13485:2012. The companys investors include: Seroba Kernel Life Sciences, Omnes Capital, ACT Venture Capital and Seroba Bioventures.
Novate Medical Ltd. is a privately held medical device company founded in 2006 and focused on the prevention of pulmonary embolism in patients at high risk of venous thromboembolic events. The companys lead product, called Sentry, is the first bio-convertible IVC filter. It is designed to provide protection against PE during the patients high risk period and then to bioconvert to leave an unobstructed IVC lumen after a minimum of sixty (60) days. This unique feature removes the requirement for an additional interventional procedure to retrieve the device. Novate is headquartered in Ireland and has offices in Ireland, the United Kingdom and the United States. It operates under the quality system requirements of ISO 13485:2012. The companys investors include: Seroba Kernel Life Sciences, Omnes Capital, ACT Venture Capital and Seroba Bioventures.
Company Information
- Industry
- Medical Devices
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- City
- Region
- New York
- Postal Code
- Country